SSY Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SSY Group Ltd with three other
companies in this sector in China:
Anhui Fengyuan Pharmaceutical
sales of 2.03 billion Chinese Renmimbi [US$321.19 million]
of which 63%
was Medicine Retail Circulation),
Xiangxue Pharmaceutical Co Ltd
(1.86 billion Chinese Renmimbi [US$293.95 million]
of which 34%
was Chinese Herbal Medicines), and
Mayinglong Pharmaceutical Group Co Ltd
(2.10 billion Chinese Renmimbi [US$332.10 million]
of which 48%
was Pharmaceutical Circulation).
SSY Group Ltd reported sales of 2.02 billion Chinese Renmimbi (US$319.71 million)
December of 2016.
increase of 12.3%
versus 2015, when the company's sales were 1.80 billion Chinese Renmimbi.
Sales of Medical Materials saw an increase
that was more than double the company's growth rate: sales were up
224.0% in 2016, from
37.63 million Chinese Renmimbi to 121.89 million Chinese Renmimbi.